| | COMMITMENT to EXTRAVASATION TREATMENT |
| Novel research led to the only FDA approved product for treating anthracycline extravasation.
|
| TOTECT® may reduce the providers medico-legal risks and healthcare costs associated with anthracycline extravasations.
|
| TopoTarget provides the educational platform to increase awareness, detection and prevention of anthracycline extravasations.
|
| TOTECT® has orphan drug marketing exclusivity and is the only patent-protected dexrazoxane for treating anthracycline extravasations.
|
| TOTECT® Now offers a Six-Year Replacement Kit Policy on all Purchased Kits.
|
|
|
